PATENT CLAIM ANALYSIS

Application Number: 15993214
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "236500"]

Abstract:
The present invention relates to the use of substituted pyrazole derivatives to modulate tropomyosin-related kinase (Trk) family protein kinase, and the use of the substituted pyrazole derivatives for the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA.

Claim (Index 13):
The method of  claim 12 , wherein the disease or disorder is pain.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.62
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14440817', '15285234', '13377031', '14775434', '13376814']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7828838185225626
- 35 USC 102 Novelty (BERT): 0.529398855954065
- Combined Prediction Score: 0.7575353222657129
- Mean Citation Score: 312.008996
- Max Citation Score: 326.78836
- Similarity Product: 197.4264988118481

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test